Features

Carole Scrafton discusses her experience living with Ehlers-Danlos syndrome alongside other rare conditions that have manifested throughout her...

The opioid crisis has been a disaster decades in the making. Conor Kavanagh breaks down the records and proposals of the leading candidates for...

"Cutting edge science and the possibility of helping people who really need it keeps me driven. It was this dynamism that originally attracted me...

Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates how developments in AI...

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a...

Following the launch of a new global report, ‘Supporting Women With Cancer’, Lynn Taylor, Senior Vice President, Head of Healthcare Global...

Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the industry...

“The main secret is a mix of science and business – the two cannot be separated”

Dr Arthur Roach, Director of Research at the charity Parkinson's UK, discusses new trials on cannabidiol in the treatment of Parkinson’s-related...

With mergers and acquisitions back in full swing after a period of drought, Alec Burnside (Partner) and Delphine Strohl (Associate) of global law...